Add like
Add dislike
Add to saved papers

Ewing sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells.

Cancer Res Commun 2023 October 13
Novel therapeutic strategies are urgently needed for high-risk Ewing sarcoma (EwS) patients and for the reduction of severe side-effects for all patients. Immunotherapy may fill this need, but its successful application has been hampered by a lack of knowledge on the composition and function of the EwS immune microenvironment. Here, we explore the immune microenvironment of EwS, by single-cell RNA sequencing of 18 EwS primary tissue samples. EwS is infiltrated by NK, T, and B cells, dendritic cells, and immunosuppressive macrophages. EwS-associated T cells show various degrees of dysfunction. The antigen-presenting cells found in EwS lack co-stimulatory gene-expression, implying functional impairment. Interaction analysis reveals a clear role for EwS tumor cells in turning the EwS immune microenvironment into an immunosuppressive niche. These results provide novel insights into the functional state of immune cells in the EwS tumor microenvironment and suggest mechanisms by which EwS tumor cells interact with, and shape, the immune microenvironment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app